Stockscreener 앱 받기
7.15
0.28%
0.02
Instil Bio Inc 주식(TIL)의 최신 뉴스
TIL|Instil Bio Inc|Price:7.203|Chg%:+0.073 - TradingKey
Instil Bio Inc (TIL) Balance Sheet - TradingKey
Instil Bio Inc (TIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Instil Bio Inc (TIL) Income Statement - TradingKey
Instil Bio Inc (TIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TIL|Instil Bio Inc|Price:7.130|Chg%:-0.070 - TradingKey
Instil Bio Inc (TIL) Cash Flow - TradingKey
Instil Bio, Inc. Revenue Breakdown – NASDAQ:TIL - TradingView
TIL|Instil Bio Inc|Price:7.150|Chg%:+0.020 - TradingKey
Instil Bio Inc (TIL) Institutional Confidence - TradingKey
Instil Bio Inc (TIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Avoiding Lag: Real-Time Signals in (TIL) Movement - Stock Traders Daily
TIL Q1 2026 Earnings: Wider-Than-Expected Loss Amid Preclinical Pipeline ActivityEarnings Preview - dars.gov.et
Instil Bio Inc. (TIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Reports Wider Loss - DonanımHaber
Instil Bio (TIL) edges higher as shares test key support-resistance rangeTriangle Correction - DonanımHaber
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Investors to Inquire about Securities Investigation - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (T - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Discipline and Rules-Based Execution in TIL Response - Stock Traders Daily
Enterprise value to EBIT forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to book forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to sales forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to earnings forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
TIL Q1 2026 Earnings: EPS Miss Reflects Increased R&D Spend as Pipeline AdvancesOne-Time Gain Impact - dars.gov.et
Instil Bio, Inc. Actuals & Estimates (NASDAQ:TIL) - TradingView
5GT0 Forecast — Price Target — Prediction for 2027 - TradingView
TIL Forecast — Price Target — Prediction for 2027 - TradingView
Instil Bio Inc (TIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Instil Bio Q1 2026 Earnings: Narrow EPS Miss, No Revenue, and Modest Stock UptickShare Dilution Risk - dars.gov.et
Instil Bio Inc (TIL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Behavioral Patterns of TIL and Institutional Flows - Stock Traders Daily
Instil Bio Inc (TIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Instil Bio Inc (TIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Instil Bio Inc (TIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Instil Bio (TIL) director awarded stock options for 6,500 shares at $7.93 - Stock Titan
Instil Bio (NASDAQ: TIL) director receives grant of 6,500 stock options - Stock Titan
Instil Bio (TIL) director awarded 6,500 stock options at $7.93 strike - Stock Titan
Instil Bio (TIL) director Gwendolyn Binder awarded 6,500 stock options at $7.93 - Stock Titan
Instil Bio Shareholders Back Directors and Auditor at Meeting - TipRanks
[8-K] Instil Bio, Inc. Reports Material Event - Stock Titan
Instil Bio Inc. (TIL) Edges Lower as Stock Tests Key Support ZoneWave Truncation - newsline.com
Instil Bio Inc. Q1 2026 Earnings: EPS Misses Estimates Amid No RevenueBasic EPS Analysis - newsline.com
TIL Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued R&D Investment Amid No RevenueEPS Growth Rate - newsline.com
(TIL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TIL Technical Analysis | Trend, Signals & Chart Patterns | INSTIL BIO INC (NASDAQ:TIL) - ChartMill
TIL Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Navigates Early PipelineEstimate Accuracy - newsline.com
TILInstil Bio Inc Stock Price and Quote - Finviz
How (TIL) Movements Inform Risk Allocation Models - Stock Traders Daily
TIL News | INSTIL BIO INC (NASDAQ:TIL) - ChartMill
TIL Q1 2026 Earnings: Wider-than-Expected Loss Highlights Early-Stage Development ChallengesCapex Guidance - The Legal Advocate
Instil Bio Inc. (TIL) Holds Steady Near Key Support After Modest UptickShort Setup Alerts - The Legal Advocate
Instil Bio Q1 2026 Earnings: EPS Miss as Development-Stage Company Reports No Revenue; Stock Edges UpROA Comparison - The Legal Advocate
Instil Bio Q1 2026 Earnings: EPS Miss Reflects Ongoing R&D InvestmentFinancial Health Score - The Legal Advocate
Instil Bio Inc. (TIL) Q1 2026 Earnings: Wider-Than-Expected Loss as Biotech Continues Pre-Commercial PhaseFree Market Insights - Newser
Instil Bio (TIL) Q1 2026 Results Fall Short — EPS $-0.62, Revenue $N/AStock Idea Network - Newser
Trading Systems Reacting to (TIL) Volatility - Stock Traders Daily
1.97%
0.83%
자본화:
|
볼륨(24시간):